|
Current issue
Archive
Online First
About the journal
Editorial board
Editorial office
Publisher
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
5/2005
vol. 4 abstract:
Genetic polymorphisms in coagulation and fibrinolysis systems versus thromboembolic risk of estrogen-progestin therapies in women
Grzegorz Stachowiak
,
Tomasz Stetkiewicz
,
Sławomir Jędrzejczyk
,
Anna Sobczuk
,
Andrzej Makuła
,
Tomasz Pertyński
Prz Menopauz 2005; 5: 59–64
Online publish date: 2005/11/02
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
This article is a survey of some genetic polymorphisms present in coagulation and fibrinolysis systems, with potential influence on the thromboembolic risk of oral contraception and hormone therapy of the menopausal period. It seems that these thrombophilic anomalies are responsible in part for the increased thrombotic risk being characteristic in particular for the first year of sex steroid administration in women.
keywords:
genetic polymorphisms, menopause, coagulation, fibrinolysis, hormone therapy, oral contraception |
 |
